The use of mathematical modeling to inform drug policy making
- PMID: 32312601
- PMCID: PMC7164851
- DOI: 10.1016/j.drugpo.2020.102759
The use of mathematical modeling to inform drug policy making
Conflict of interest statement
Declaration of Interests NM has received unrestricted research grants from Gilead and Merck unrelated to this work. PV has received unrestricted research grants from Gilead unrelated to this work.
References
-
- Eaton J.W., Menzies N.A., Stover J., Cambiano V., Chindelevitch L., Cori A., et al. Health benefits, costs, and cost-effectiveness of earlier eligibility for adult antiretroviral therapy and expanded treatment coverage: A combined analysis of 12 mathematical models. The Lancet Global Health. 2014;2(1):e23–e34. doi: 10.1016/s2214-109x(13)70172-4. - DOI - PubMed
-
- Godin A., Kronfli N., Cox J., Alary M., Maheu-Giroux M. The role of prison-based interventions for hepatitis C virus (HCV) micro-elimination among people who inject drugs in Montréal, Canada. International Journal of Drug Policy. 2020 [in press] - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
